CClinicalTrials.gg
TerminatedNCT04118894Updated Jan 14, 2025Results posted

Wright Foot & Ankle Post-Market Observational Study

An observational study in Arthritis, Rheumatoid Arthritis and Fracture, sponsored by Stryker Trauma and Extremities. Terminated at 5 sites in 4 countries. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-14.

Sponsored by Stryker Trauma and Extremities · Observational

Why this study was terminated
Due to COVID the enrollment into the study was delayed. Sponsor chose to collect clinical data via alternative methods.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
119
Ages
18 Years and older
Sex
All
01

Study summary

WRIGHT FOOT \& ANKLE POST-MARKET OBSERVATIONAL STUDY, Multi-Year, Multi-Site, Multi-Device, Post-Market Observational Study, 10 sites, a minimum of 40 patients per device

Read the detailed description

The selected design is a global, multi-center, non-randomized, prospective observational study. The study subjects included are those treated with one or more approved or cleared Wright Medical products included in this study.

02

Conditions studied

  • Arthritis
  • Rheumatoid Arthritis
  • Fracture
  • Trauma Injury
  • Fusion of Joint

Browse trials for

03

In context

Arthritis

3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.

This study's enrollment of 119 is below the median of 155 across 1,057 observational studies indexed under Arthritis.

Browse Arthritis studies →

Lead sponsor

Stryker Trauma and Extremities is the lead sponsor of 43 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The Instructions for Use (IFU) for each individual product can be found at http://www.wright.com/prescribing-use-3.

Inclusion criteria

  • Willing and able to consent to participate (written, informed consent);
  • Willing and able to attend/complete the requested follow-up visits;
  • Considered for treatment with one or more approved or cleared Wright Medical products included in this study

Exclusion criteria

Exclusion Criteria:

  • Subjects determined, by the investigator, to be an inappropriate candidate for the procedure indicated;
  • Unable to consent to participate (written, informed consent);
  • Unable to attend/complete the requested follow-up visits
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
119 participants (actual)
Patient registry
No

Groups and cohorts

  • Foot and Ankle Devices

    The study subjects included are those treated with one or more approved or cleared Wright Medical products included in this study.

    Device: Foot and Ankle Devices

Interventions

  • DeviceFoot and Ankle Devices

    Wright devices used in foot and ankle procedures

06

What researchers measure

Primary outcomes

  1. EuroQol (EQ-5D-5L).

    Comparing the changes in patient-reported pain and social interaction for quality of life from pre-op through post-operatively, assessed by the EuroQol (EQ-5D-5L). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. This decision results in a 1-digit number that expresses the level selected for that dimension. Health utility values generated from the EQ-5D generally range from 0 (death) to 1 (perfect health). But health utility values less than 0 are possible, and represent health states considered worse than death. The EQ VAS records the patient's self-rated health on a VAS (0-100), where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'.

    Time frame: 1 year

Secondary outcomes

  1. Foot and Ankle Ability Measure (FAAM)

    Comparing the changes in patient-reported function scores from pre-op through post-operatively, assessed by the FAAM The FAAM is a patient-completed instrument that consists of an "Activities of Daily Living" subscale (21 scored items) and a "Sports" subscale (7 scored items) in which the response options are presented as 5-point Likert scales (range 4 to 0). Scores for each subscale range from 0% (least function) to 100% (most function).

    Time frame: 1 year

  2. Safety Assessment

    Identifying and reporting the safety of the implant in terms of complications and adverse events. (This is reported in the Adverse Event Section)

    Time frame: 1 year

  3. Surgeon Survey

    Conducting a surgeon survey including radiographic assessment of fusion and consolidation time

    Time frame: 1 year

  4. Patient Survey

    Conducting patient surveys to assess current implant status (to include complications)

    Time frame: 1 year

07

Results

Posted Jan 14, 2025

Participant flow

Overall, 119 subjects were enrolled and treated with a study device at 5 sites in the private clinic and hospital setting in the France, Germany, United States and United Kingdom. A subject may have received more than one of the devices under investigation. The first subject was enrolled on January 22, 2020 (aligned with protocol) and the last subject was enrolled on November 1, 2021.

Participant flow — Overall Study
MilestoneFoot and Ankle Devices
Started119
Completed84
Not completed35
Withdrew: Lost to follow-up21
Withdrew: Withdrawal by subject10
Withdrew: Adverse event4

Outcome measures

PrimaryEuroQol (EQ-5D-5L).

Comparing the changes in patient-reported pain and social interaction for quality of life from pre-op through post-operatively, assessed by the EuroQol (EQ-5D-5L). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. This decision results in a 1-digit number that expresses the level selected for that dimension. Health utility values generated from the EQ-5D generally range from 0 (death) to 1 (perfect health). But health utility values less than 0 are possible, and represent health states considered worse than death. The EQ VAS records the patient's self-rated health on a VAS (0-100), where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'.

Time frame:
1 year
Reported as:
Mean · units on a scale- EQ5D VAS
EuroQol (EQ-5D-5L).
units on a scale- EQ5D VASFoot and Ankle Devices
EuroQol (EQ-5D-5L).74.1 ± 22.5
SecondaryFoot and Ankle Ability Measure (FAAM)

Comparing the changes in patient-reported function scores from pre-op through post-operatively, assessed by the FAAM The FAAM is a patient-completed instrument that consists of an "Activities of Daily Living" subscale (21 scored items) and a "Sports" subscale (7 scored items) in which the response options are presented as 5-point Likert scales (range 4 to 0). Scores for each subscale range from 0% (least function) to 100% (most function).

Time frame:
1 year
Reported as:
Mean · score on a scale- FAAM SANE
Foot and Ankle Ability Measure (FAAM)
score on a scale- FAAM SANEFoot and Ankle Devices
Foot and Ankle Ability Measure (FAAM)68.6 ± 25.5
SecondarySafety Assessment

Identifying and reporting the safety of the implant in terms of complications and adverse events. (This is reported in the Adverse Event Section)

Time frame:
1 year
Reported as:
Count of participants · Participants
Safety Assessment
ParticipantsFoot and Ankle Devices
Subjects that Experienced a Serious Adverse Event9
Subjects that Didn't Experience a Serious Adverse Event110
SecondarySurgeon Survey

Conducting a surgeon survey including radiographic assessment of fusion and consolidation time

Time frame:
1 year
Reported as:
Count of participants · Participants
Surgeon Survey
ParticipantsFoot and Ankle Devices
Wright product performed as intended- Yes109
Wright product performed as intended- No3
SecondaryPatient Survey

Conducting patient surveys to assess current implant status (to include complications)

Time frame:
1 year
Reported as:
Count of participants · Participants
Patient Survey
ParticipantsFoot and Ankle Devices
Experienced any complications associated with your procedure requiring you to seek medical care? — Yes7
Experienced any complications associated with your procedure requiring you to seek medical care? — No42
Any surgery to remove any device parts associated with your foot/ankle procedure? — Yes1
Any surgery to remove any device parts associated with your foot/ankle procedure? — No48

Adverse events

Collected over Surgery to 1 year. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Foot and Ankle Devices0/119 (0%)9/119 (7.6%)19/119 (16%)
Most frequent serious events
Most frequent serious events
EventFoot and Ankle Devices
InfectionMusculoskeletal and connective tissue disorders4/119
PainMusculoskeletal and connective tissue disorders2/119
acute aortic dissectionCardiac disorders1/119
Below Knee AmputationMusculoskeletal and connective tissue disorders1/119
Non-UnionMusculoskeletal and connective tissue disorders1/119
Most frequent other events
Most frequent other events
EventFoot and Ankle Devices
PainMusculoskeletal and connective tissue disorders12/119
Wound Healing ComplicationsMusculoskeletal and connective tissue disorders5/119
AlgodystrophyMusculoskeletal and connective tissue disorders1/119
Blister Dorsal Aspect of Operated FootMusculoskeletal and connective tissue disorders1/119
Inflammatory ScarMusculoskeletal and connective tissue disorders1/119
UlcerMusculoskeletal and connective tissue disorders1/119

Baseline characteristics

Age, Continuous
Age, Continuous(years)Foot and Ankle Devices
Mean59.49 ± 13.34
Sex: Female, Male
Sex: Female, Male(Participants)Foot and Ankle Devices
Female79
Male40
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Foot and Ankle Devices
Smoking Status
Smoking Status(Participants)Foot and Ankle Devices
Never77
Previous38
Current, <= 1 Pack/day3
Current, > 1 pack/day1
BMI
BMI(kg/m^2)Foot and Ankle Devices
Mean28.18 ± 5.58
08

Study locations

5 sites
  • Mercer-Bucks Orthopaedics
    Hamilton, New Jersey 08691, United States
  • OrthoCarolina
    Charlotte, North Carolina 28207, United States
  • CHRU Tours, Hôpital Trousseau
    Tours, 37044, France
  • Hessingpark Clinic
    Augsburg, Germany
  • Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust
    Oswestry, Shropshire, United Kingdom
09

References and documents

Study documents

  • Study protocol · Apr 18, 2019
  • Statistical analysis plan · Dec 7, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04118894
Lead sponsor
Stryker Trauma and Extremities
Responsible party
Sponsor
First posted
Oct 8, 2019
Start date
Jan 22, 2020
Primary completion
Dec 8, 2022
Completion
Jul 12, 2023
Results posted
Jan 14, 2025
Last update
Jan 14, 2025

Study contacts

Rebecca Gibson
study director · Stryker Trauma and Extremities

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion